當升科技(300073.SZ):管理層與核心骨幹股權增持計劃完成購買 合計買入202.58萬股
格隆匯 10 月 19日丨當升科技(300073.SZ)發佈關於管理層與核心骨幹股權增持計劃完成購買的公告,2020年9月17日-10月16日期間,公司股權增持計劃未買入公司股份。
截至2020年10月16日,公司股權增持計劃的買入期限已屆滿,後續將不再買入公司股票。至此,公司此次股權增持計劃已通過“長江養老保險股份有限公司-長江盛世華章集合型團體養老保障管理產品進取增利6號”以二級市場競價方式合計買入公司股票202.58萬股,佔公司總股本的0.46%,成交均價約為26.18元/股,成交總金額為5304.02萬元,其餘未買入股票的資金將用於申購新股及配置長江養老理財產品。此次股權增持計劃的鎖定期為2020年6月18日-2021年6月17日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.